RE: MCap15 Oct 2020 22:19
Great post Adam.
I’m absolutely certain that this little decapeptide has a very valuable use (possibly many valuable uses). Finding it is the key. Unfortunately we don’t have the money to throw at it like some other companies, to investigate the potential uses across a range of diseases (take dasatinib, for instance...they saw the potential in the prostate trials, then when it underperformed in the phase three, due to it not being as specific as 201, they immediately trialled it for leukaemia where it is now very successful for certain types). So we have to sit and wait for someone else to do this final bit for us, such as the Japanese company.
We know the potential for tyrosine kinase inhibitors and ours is very specific within this realm, as we know.
Great point about our sp not being artificially buoyed by a Covid play. Trust me I know all about this, having been in SNG since the 30’s and still there (convinced we will clean up there, by the way). So if we do get somewhere with the Covid angle, then it will be a very welcome bonus.